Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Fifty 410
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict55/ 100
Grade C · #415Fifty 410
Compounded GLP-1 telehealth with no subscription; medication ships upfront. Its headline price is a three-month prepaid starter-dose bundle, and it carries an FDA warning letter from February 2026.
Visit Fifty 410The verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 55/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Fifty 410 still earns its place — someone who wants a single upfront payment with no recurring billing and is content to buy a fixed three-month tirzepatide course rather than titrate month by month.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results62
92
Real-world results62
97Price honesty40
97
Price honesty40
96Prescriber access66
96
Prescriber access66
88Formulary choice48
88
Formulary choice48
95Cancellation fairness58
95
Cancellation fairness58
93Member support58
93
Member support58
Price, coverage & features
| Metric | CoreAge Rx | Fifty 410 |
|---|---|---|
| Verdict Score | 94/100 | 55/100 |
| Grade | A | C |
| Semaglutide | $99/mo | $199/mo |
| Tirzepatide | $149/mo | $299/mo |
| Coverage | All 50 states | Multi-state |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Fifty 410
What we like
- No membership or subscription: you pay once per program and there are no recurring charges
- No card is required to start and you are only billed if a licensed provider approves you
- Semaglutide is genuinely month-to-month at $199 with all dosages included
- Free overnight or two-day refrigerated shipping is included in every program price
- Now carries explicit disclaimers that it is not the compounder and that compounded medicines are not FDA-approved finished drug products
The caveats
- FDA issued a warning letter to Aspen Aesthetics dba Fifty 410 in February 2026; it is public in FDA's warning-letter database
- Compounded only, and compounded GLP-1s are not FDA-approved; no brand-name Wegovy, Zepbound, Ozempic or Mounjaro
- The advertised '$133/month' is a three-month prepaid starter-dose tirzepatide bundle ($399 up front); the pricing page loads on that tab by default and the FAQ repeats it as 'start at $133/month'
- Month-to-month tirzepatide at $299 appears only on the homepage toggle and has no corresponding option on the pricing page
- No list of served states is published anywhere on the site, and no support phone number is given
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Someone who wants a single upfront payment with no recurring billing and is content to buy a fixed three-month tirzepatide course rather than titrate month by month.
Visit Fifty 410 Read the full Fifty 410 review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Fifty 410 does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.